NA17 Peptide Amino acid sequence VLPDVFIRCV
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent ->
Antigen ->
Vaccine Antigen -> NA17 Peptide Amino acid sequence VLPDVFIRCV
NA17 Peptide Amino acid sequence VLPDVFIRCV Definition
A synthetic peptide vaccine derived from the melanoma antigen NA17. Dendritic cells (DC) harvested from a cancer patient may be exposed to or pulsed with the NA17 peptide (VLPDVFIRCV). Autologous vaccination with these altered dendritic cells may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for NA17, resulting in decreased tumor growth. (NCI04)
NA17 Peptide Amino acid sequence VLPDVFIRCV Synonyms
NA17 Peptide (Amino acid sequence VLPDVFIRCV)
Terms in NA17 Peptide Amino acid sequence VLPDVFIRCV category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.